SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

H.C. Wainwright Reiterates Buy on Syndax Pharmaceuticals, Raises Price Target to $25

H.C. Wainwright analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $19 to $25.

Benzinga · 05/11/2020 11:27

H.C. Wainwright analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $19 to $25.